Biologic Infusion Reactions: Management Guide | MDster You are offline Back online! [ MDster home ](/ "MDster home") Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) Menu Specialities [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics & Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry) [ Features ](https://mdster.com/features) [ SOE Examiner NEW ](https://mdster.com/soe-examiner) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog) [ Login ](https://mdster.com/auth/login) 1. [ Home ](https://mdster.com) 2. [ Blog ](https://mdster.com/blog) 3. [ Medical Education ](https://mdster.com/blog?category=medical-education) 4. Infusion Reactions to Biologics: Management and Desensitization [ Medical Education ](https://mdster.com/blog?category=medical-education) Infusion Reactions to Biologics: Management and Desensitization ================================================================= A high-yield Internal Medicine guide to recognizing, treating, preventing, and safely rechallenging biologic hypersensitivity reactions. [ MDster Editorial Team ](https://mdster.com/about) · May 31, 2026 · 5 min read · 322 [ Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections) [ Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ Anaphylaxis ](https://mdster.com/blog?tag=anaphylaxis) [ Biologic Therapy ](https://mdster.com/blog?tag=biologic-therapy) [ Drug Hypersensitivity ](https://mdster.com/blog?tag=drug-hypersensitivity) [ High-Risk Medications ](https://mdster.com/blog?tag=high-risk-medications) ![Infusion Reactions to Biologics: Management and Desensitization](https://mdster.com/storage/blog/images/infusion-reactions-to-biologics-management-and-desensitization.jpg) Share this article Share this post On this page 1. [ Start With the Phenotype, Not the Drug Name ](#start-with-the-phenotype-not-the-drug-name) 2. [ Immediate Management: Stop, Stabilize, Stratify ](#immediate-management-stop-stabilize-stratify) 3. [ Premedication: Useful, Not Magical ](#premedication-useful-not-magical) 4. [ Desensitization: Temporary Tolerance, Not Forgiveness ](#desensitization-temporary-tolerance-not-forgiveness) 5. [ Clinical Correlations for Internal Medicine ](#clinical-correlations-for-internal-medicine) 6. [ Key Takeaways ](#key-takeaways) 7. [ Frequently Asked Questions ](#blog-faqs) 8. [ References ](#references-heading) On this page 1. [ Start With the Phenotype, Not the Drug Name ](#start-with-the-phenotype-not-the-drug-name) 2. [ Immediate Management: Stop, Stabilize, Stratify ](#immediate-management-stop-stabilize-stratify) 3. [ Premedication: Useful, Not Magical ](#premedication-useful-not-magical) 4. [ Desensitization: Temporary Tolerance, Not Forgiveness ](#desensitization-temporary-tolerance-not-forgiveness) 5. [ Clinical Correlations for Internal Medicine ](#clinical-correlations-for-internal-medicine) 6. [ Key Takeaways ](#key-takeaways) 7. [ Frequently Asked Questions ](#blog-faqs) 8. [ References ](#references-heading) A patient getting their first rituximab infusion develops flushing, rigors, throat tightness, and falling BP 40 minutes into the bag. This is where biologic safety stops being theoretical. The intern who reaches first for diphenhydramine may be treating hives while missing anaphylaxis. Start With the Phenotype, Not the Drug Name ------------------------------------------- Biologic infusion reactions are not one entity. The bedside question is: **Is this cytokine release, mast-cell mediated hypersensitivity, or a severe delayed immune reaction beginning to declare itself?** Rituximab labeling notes that severe, even fatal, infusion reactions can occur, often with the first infusion; common first-infusion symptoms include fever, chills, pruritus, angioedema, hypotension, bronchospasm, and urticaria. [\[1\]](#cite-1 "Reference [1]") PatternTypical cluesImmediate implicationCytokine-release/infusion reactionFever, rigors, flushing, myalgias, mild dyspneaPause, assess severity, restart slowly only if stableIgE/mast-cell reactionUrticaria, angioedema, wheeze, hypotension, GI symptomsTreat as anaphylaxis; epinephrine firstSerum sickness/SCARDelayed fever, rash, arthralgia, mucosal or systemic signsDo not simply rechallenge Board exams love the trap: “infusion reaction” sounds benign. Do not let the label override physiology. Immediate Management: Stop, Stabilize, Stratify ----------------------------------------------- For any concerning reaction, stop the biologic and keep IV access with normal saline. Check airway, breathing, circulation, mental status, pulse oximetry, and BP. Call for help early; outpatient infusion suites must have oxygen, suction, epinephrine, bronchodilator, IV fluids, and a transfer plan. If there is hypotension, bronchospasm, stridor, angioedema, or multisystem involvement, give **IM epinephrine immediately**. WAO guidance supports IM epinephrine as first-line therapy, 0.01 mg/kg up to 0.5 mg in adults, repeated every 5–15 minutes if needed. [\[2\]](#cite-2 "Reference [2]") Antihistamines and corticosteroids are adjuncts; they do not reverse shock or airway edema. A practical sequence: 1. Stop infusion; maintain line with saline. 2. Give IM epinephrine for suspected anaphylaxis. 3. Position supine with legs elevated unless respiratory distress requires upright posture. 4. Add high-flow oxygen, IV crystalloid boluses, albuterol for bronchospasm. 5. Use H1 antihistamine, H2 blocker, antipyretic, or corticosteroid only after epinephrine when indicated. 6. Document timing, symptoms, vitals, drugs given, and response. For mild isolated symptoms—limited flushing, pruritus, or rigors with stable vitals—pause and treat supportively. If symptoms fully resolve, restart only according to the product label and institutional protocol, often at a reduced rate. Rituximab labeling allows resumption at a minimum 50% rate reduction after certain nonsevere reactions, but severe reactions require discontinuation and medical management. [\[3\]](#cite-3 "Reference [3]") > **Clinical Pearl:** Never “push through” throat tightness, wheeze, syncope, or hypotension during a biologic infusion. Those are epinephrine signs, not diphenhydramine signs. Premedication: Useful, Not Magical ---------------------------------- Premedication is risk reduction, not immunity. Acetaminophen plus an H1 antihistamine is common before rituximab; IV glucocorticoid is recommended in several autoimmune indications before rituximab. [\[4\]](#cite-4 "Reference [4]") Infliximab labeling also emphasizes monitoring during infusion and discontinuation for serious reactions. [\[5\]](#cite-5 "Reference [5]") Use premedication strategically: - Give routine premeds when required by the biologic label or protocol. - Consider corticosteroid, antihistamine, slower rate, or longer observation after prior mild reactions. - Do not use premedication to justify rechallenge after anaphylaxis without Allergy/Immunology input. - Remember that premeds can blunt fever, rash, and early warning signs. Boards often test this principle: steroids may reduce some infusion symptoms, but **epinephrine remains first-line for anaphylaxis**. A patient on beta-blockers may have more difficult shock physiology, but that is not a reason to withhold IM epinephrine. Desensitization: Temporary Tolerance, Not Forgiveness ----------------------------------------------------- Desensitization is for patients who need the culprit biologic and lack an equally effective alternative. It is usually considered after immediate hypersensitivity or severe infusion reactions when benefit clearly outweighs risk. Rapid drug desensitization uses stepwise exposure through increasingly concentrated solutions and rates, creating temporary tolerance; it must be repeated whenever the drug is given after tolerance wanes. [\[6\]](#cite-6 "Reference [6]") Do not desensitize casually. Refer to Allergy/Immunology for phenotype review, tryptase interpretation when available, skin testing when appropriate, and protocol selection. The 2023 anaphylaxis practice update emphasizes that epinephrine can be appropriate before full diagnostic criteria are met and that acute tryptase should be drawn as early as possible, ideally within 2 hours, with a later baseline for comparison. [\[7\]](#cite-7 "Reference [7]") Avoid desensitization for severe delayed reactions such as SJS/TEN, DRESS, severe mucocutaneous reactions, or convincing serum sickness unless an expert team identifies an exceptional circumstance. These are not mast-cell problems; incremental dosing may worsen immune injury. Clinical Correlations for Internal Medicine ------------------------------------------- Rheumatology, gastroenterology, oncology, and allergy all share this territory. Your job as the internist is to identify risk, recognize deterioration, and coordinate the next safe dose. High-risk clues include: - First rituximab infusion or high tumor burden. - Prior infusion reaction, especially respiratory or cardiovascular. - Treatment interruption with possible anti-drug antibody formation. - Asthma, mast-cell disorder, or limited access to emergency care. Key Takeaways ------------- - Treat the patient’s physiology, not the phrase “infusion reaction.” - Stop the infusion first; give IM epinephrine early for anaphylaxis. - Antihistamines and steroids are adjuncts, not substitutes. - Premedication lowers risk but can mask evolving severity. - Desensitization creates temporary tolerance and requires specialist oversight. - Never rechallenge severe delayed hypersensitivity as if it were a mild infusion reaction. Biologics are powerful because they are immunologically active. Respect that biology at the infusion chair. The safest clinicians are not the ones who avoid reactions entirely; they are the ones who recognize the phenotype quickly, treat anaphylaxis decisively, and plan the next exposure deliberately. Frequently Asked Questions ---------------------------- ### When should I give epinephrine during a biologic infusion reaction? Give IM epinephrine immediately for hypotension, bronchospasm, stridor, angioedema, syncope, or multisystem involvement. Do not wait for rash. ### Can I restart a biologic after a mild infusion reaction? Often yes, if symptoms fully resolve and vitals remain stable, but restart at a reduced rate only per product labeling and local protocol. ### Do premedications prevent anaphylaxis to biologics? No. Acetaminophen, antihistamines, and corticosteroids may reduce some reactions, but they do not reliably prevent or treat anaphylaxis. ### Who should undergo biologic desensitization? Patients with immediate hypersensitivity who still require the biologic and lack a good alternative may be candidates after Allergy/Immunology evaluation. ### Is desensitization permanent? No. Desensitization produces temporary tolerance and usually must be repeated with each future dose after a dosing gap. References (8) ------------------ 1. 1. [ DailyMed: Rituxan (rituximab) prescribing information ](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b172773b-3905-4a1c-ad95-bab4b6126563) [↩](#cite-ref-1-1 "Back to text") 2. 2. [ hstcsa.co.za/wp-content/uploads/2024/05/a.pdf ](https://hstcsa.co.za/wp-content/uploads/2024/05/a.pdf) [↩](#cite-ref-2-1 "Back to text") 3. 3. [ www.accessdata.fda.gov/drugsatfda\_docs/label/2021/103705s5467lbl.pdf ](https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/103705s5467lbl.pdf) [↩](#cite-ref-3-1 "Back to text") 4. 4. [ dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=b172773b-3905-4a1c-ad95-bab4b6126563&type=pdf ](https://dailymed.nlm.nih.gov/dailymed/getFile.cfm?setid=b172773b-3905-4a1c-ad95-bab4b6126563&type=pdf) [↩](#cite-ref-4-1 "Back to text") 5. 5. [ FDA: Remicade (infliximab) prescribing information ](https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/103772s5412lbl.pdf) [↩](#cite-ref-5-1 "Back to text") 6. 6. [ Desensitization to biological agents used in rheumatology. Reumatologia, 2020 ](https://pmc.ncbi.nlm.nih.gov/articles/PMC7174799/) [↩](#cite-ref-6-1 "Back to text") 7. 7. [ Wang et al. Anaphylaxis in Practice: A Guide to the 2023 Practice Parameter Update. JACI: In Practice, 2024 ](https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Allergist%20Resources/Statements%20and%20Practice%20Parameters/Anaphylaxis-in-Practice-2023.pdf) [↩](#cite-ref-7-1 "Back to text") 8. 8. [ World Allergy Organization Anaphylaxis Guidance 2020 ](https://doi.org/10.1016/j.waojou.2020.100472) Next Turn reading into Internal Medicine performance ------------------------------------------------- - System‑based, exam‑style questions + explanations - Smarter review to reinforce weak topics - Build confidence with measurable progress [ Start practicing ](https://mdster.com/user/dashboard) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features) No credit card required. Full access to all features\*. No commitment. Cancel anytime. \*AI SOE Examiner is limited to 10 cases monthly for Advanced & Bundle subscribers. Explore topics: [ # Internal Medicine ](https://mdster.com/blog?tag=internal-medicine) [ # Anaphylaxis ](https://mdster.com/blog?tag=anaphylaxis) [ # Biologic Therapy ](https://mdster.com/blog?tag=biologic-therapy) [ # Drug Hypersensitivity ](https://mdster.com/blog?tag=drug-hypersensitivity) [ # High-Risk Medications ](https://mdster.com/blog?tag=high-risk-medications) [ Back to all posts ](https://mdster.com/blog) Discussion () ----------------- Join the discussion [ Log in ](https://mdster.com/auth/login) or [ Sign up ](https://mdster.com/auth/register) No comments yet Be the first to share your thoughts! ![]() More in Medical Education ------------------------- [ See all ](https://mdster.com/blog?category=medical-education) [### QI Methods and Measurement in Anesthesiology: PDSA and Charts 5 min read Aug 30, 2026 ](https://mdster.com/blog/qi-methods-and-measurement-in-anesthesiology-pdsa-and-charts) [### CPD and Lifelong Learning in Emergency Medicine: Stay Competent 4 min read Aug 29, 2026 ](https://mdster.com/blog/cpd-and-lifelong-learning-in-emergency-medicine-stay-competent) [### Mood, Affect, and Emotional Reactivity: A High-Yield MSE Guide 5 min read Aug 28, 2026 ](https://mdster.com/blog/mood-affect-and-emotional-reactivity-a-high-yield-mse-guide) Related Posts ------------- [ ![QI Methods and Measurement in Anesthesiology: PDSA and Charts](https://mdster.com/storage/blog/images/qi-methods-and-measurement-in-anesthesiology-pdsa-and-charts.jpg) Medical Education ### QI Methods and Measurement in Anesthesiology: PDSA and Charts Learn how anesthesiology teams use PDSA cycles, time-series charts, and the Donabedian framework to measure change and improve perioperative safety. 5 min read 0 comments ](https://mdster.com/blog/qi-methods-and-measurement-in-anesthesiology-pdsa-and-charts) [ ![CPD and Lifelong Learning in Emergency Medicine: Stay Competent](https://mdster.com/storage/blog/images/cpd-and-lifelong-learning-in-emergency-medicine-stay-competent.jpg) Medical Education ### CPD and Lifelong Learning in Emergency Medicine: Stay Competent A practical August 2026 review of CPD, competence maintenance, professional portfolios, and reflective practice for emergency clinicians and board candidates. 4 min read 0 comments ](https://mdster.com/blog/cpd-and-lifelong-learning-in-emergency-medicine-stay-competent) [ ![American Osteopathic Board of Internal Medicine (Internal Medicine Written Exam): Study Tips That Work](https://mdster.com/storage/blog/images/american-osteopathic-board-of-internal-medicine-internal-medicine-written-exam-study-tips.jpg) Study Tips ### American Osteopathic Board of Internal Medicine (Internal Medicine Written Exam): Study Tips That Work Prepare for the AOBIM Internal Medicine Written Exam with a focused eight-week schedule, blueprint-based priorities, timed question practice, and exam-day tactics. 5 min read 0 comments ](https://mdster.com/blog/american-osteopathic-board-of-internal-medicine-internal-medicine-written-exam-study-tips) [ ![Mood, Affect, and Emotional Reactivity: A High-Yield MSE Guide](https://mdster.com/storage/blog/images/mood-affect-and-emotional-reactivity-a-high-yield-mse-guide.jpg) Medical Education ### Mood, Affect, and Emotional Reactivity: A High-Yield MSE Guide Learn to distinguish mood from affect and assess range, congruence, lability, anhedonia, alexithymia, and emotional reactivity during the psychiatric MSE. 5 min read 0 comments ](https://mdster.com/blog/mood-affect-and-emotional-reactivity-a-high-yield-mse-guide) [ ![Confidentiality in Sexual and Reproductive Care: Clinical Rules](https://mdster.com/storage/blog/images/confidentiality-in-sexual-and-reproductive-care-clinical-rules.jpg) Medical Education ### Confidentiality in Sexual and Reproductive Care: Clinical Rules Protect reproductive health information without delaying care. Learn safer messaging, private results workflows, and minimum necessary disclosure principles. 5 min read 0 comments ](https://mdster.com/blog/confidentiality-in-sexual-and-reproductive-care-clinical-rules) [ ![Diabetic Emergencies: Hypoglycemia, DKA, and HHS Recognition](https://mdster.com/storage/blog/images/diabetic-emergencies-hypoglycemia-dka-and-hhs-recognition.jpg) Medical Education ### Diabetic Emergencies: Hypoglycemia, DKA, and HHS Recognition Recognize hypoglycemia, DKA, and HHS quickly, choose dextrose or glucagon appropriately, and identify patients requiring emergency transfer. 5 min read 0 comments ](https://mdster.com/blog/diabetic-emergencies-hypoglycemia-dka-and-hhs-recognition) [ MDster home ](/ "MDster home") Master your medical exams with evidence-based learning. [ Download on the App Store ](https://apps.apple.com/app/id6759168258) [ GET IT ON Google Play ](https://play.google.com/store/apps/details?id=com.mdster.app) Platform - [Home](https://mdster.com) - [Features](https://mdster.com/features) - [Pricing](https://mdster.com/pricing) - [About](https://mdster.com/about) Resources - [Blog](https://mdster.com/blog) - [Curriculum](https://mdster.com/curriculum) - [Dashboard](https://mdster.com/user/dashboard) Support - [Contact](https://mdster.com/contact) - [Legal & Policies](https://mdster.com/legal) - [Medical Reviewers](https://mdster.com/medical-reviewers) © 2026 MDster [ ](https://apps.apple.com/app/id6759168258) [ ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy) reCAPTCHA Protected by reCAPTCHA. Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply. Cookie Consent -------------- We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) & [ Privacy Policy ](https://mdster.com/privacy) Accept